Health care stocks rose Thursday with the NYSE Health Care Index up 1% and the Health Care Select Sector SPDR Fund (XLV) adding 1.2%.
The iShares Biotechnology ETF (IBB) advanced 1%.
In corporate news, Kazia Therapeutics' (KZIA) shares jumped 38% after the company announced the regulatory approval and launch of a trial evaluating the combination of its investigational drug paxalisib and immunotherapy in people with advanced breast cancer.
Valneva (VALN) shares rose 3.6% after the company won a $32.8 million contract from the US Department of Defense for the supply of Ixiaro, a Japanese encephalitis vaccine.
Ironwood Pharmaceuticals (IRWD) shares slumped 38%, a day after the company announced a 50% cut in its workforce due to "ongoing pricing pressures."
Cargo Therapeutics (CRGX) shares tumbled 74%, a day after the company announced plans to discontinue a phase 2 trial of firicabtagene autoleucel for people with large B-cell lymphoma and reduce its workforce by 50%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。